Helix BioPharma Corp.: First Patient Dosed in a Phase II Randomized Study of L-DOS47 With Vinorelbine and Cisplatin

March 7, 2019

We're not around right now. But you can send us an email and we'll get back to you, asap.

Start typing and press Enter to search